Literature DB >> 20512361

Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease.

Jonathan D Thiessen1, Kathryn A C Glazner, Solmaz Nafez, Angela E Schellenberg, Richard Buist, Melanie Martin, Benedict C Albensi.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that has been characterized by gross cortical atrophy, cellular neurodegeneration, reactive gliosis, and the presence of microscopic extracellular amyloid plaques and intracellular neurofibrillary tangles. Earlier diagnoses of AD would be in the best interest of managing the patient and would allow for earlier therapeutic intervention. By measuring the apparent diffusion coefficient (ADC) using diffusion-weighted imaging (DWI), a type of magnetic resonance imaging (MRI), one can quantify alterations in water diffusivity resulting from microscopic structural changes in the cell at early stages that are associated with pathophysiological processes of brain injury and/or disease progression. Whether or not this methodology is useful for AD is a question under examination. For example, DWI in suspected AD patients has shown increases in mean ADC values in the hippocampus and diminished diffusion anisotropy in the posterior white matter. However, in some cases, hippocampal ADC values appear not to change in AD patients. Moreover, to our knowledge, all DWI studies in suspected AD patients to date are technically incomplete in experimental design, because corresponding histological sections demonstrating actual plaque deposition are lacking and so it is not clear that ADC changes actually correspond to plaque deposition. In our study, we used DWI in the TgCRND8 transgenic model of Alzheimer's disease in conjunction with histological techniques and found robust plaque deposition in the transgenic strain in older animals (12-16 months old). However, we did not find statistically significant changes (p > 0.05) in ADC values (although ADC values in TgCRND8 mice did decrease in all regions examined) in mice 12-16 months old. Collectively, recent results from human studies and in rodent AD transgenic models support our findings and suggest that amyloid beta plaque load is not likely the major or primary component contributing to diffusional changes, if they occur.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512361     DOI: 10.1007/s00429-010-0271-z

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  9 in total

1.  In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.

Authors:  Wanda M Snow; Ryan Dale; Zoe O'Brien-Moran; Richard Buist; Danial Peirson; Melanie Martin; Benedict C Albensi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  In vivo quantitative whole-brain diffusion tensor imaging analysis of APP/PS1 transgenic mice using voxel-based and atlas-based methods.

Authors:  Yuan-Yuan Qin; Mu-Wei Li; Shun Zhang; Yan Zhang; Ling-Yun Zhao; Hao Lei; Kenichi Oishi; Wen-Zhen Zhu
Journal:  Neuroradiology       Date:  2013-05-05       Impact factor: 2.804

Review 3.  A review of β-amyloid neuroimaging in Alzheimer's disease.

Authors:  Paul A Adlard; Bob A Tran; David I Finkelstein; Patricia M Desmond; Leigh A Johnston; Ashley I Bush; Gary F Egan
Journal:  Front Neurosci       Date:  2014-10-31       Impact factor: 4.677

4.  Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.

Authors:  Sheryl L Herrera; Vanessa L Palmer; Heather Whittaker; Blair Cardigan Smith; Annie Kim; Angela E Schellenberg; Jonathan D Thiessen; Richard Buist; Marc R Del Bigio; Melanie Martin
Journal:  Magn Reson Insights       Date:  2014-11-09

5.  Anisotropy of Anomalous Diffusion Improves the Accuracy of Differentiating and Grading Alzheimer's Disease Using Novel Fractional Motion Model.

Authors:  Lei Du; Zifang Zhao; Boyan Xu; Wenwen Gao; Xiuxiu Liu; Yue Chen; Yige Wang; Jian Liu; Bing Liu; Shilong Sun; Guolin Ma; Jiahong Gao
Journal:  Front Aging Neurosci       Date:  2020-11-19       Impact factor: 5.750

Review 6.  Neuroimaging of Mouse Models of Alzheimer's Disease.

Authors:  Amandine Jullienne; Michelle V Trinh; Andre Obenaus
Journal:  Biomedicines       Date:  2022-01-28

7.  Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging.

Authors:  Jan Klohs; Igna Wojtyna Politano; Andreas Deistung; Joanes Grandjean; Anna Drewek; Marco Dominietto; Ruth Keist; Ferdinand Schweser; Jürgen R Reichenbach; Roger M Nitsch; Irene Knuesel; Markus Rudin
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

8.  Involvement of glial P2Y₁ receptors in cognitive deficit after focal cerebral stroke in a rodent model.

Authors:  Yo Chin; Mayo Kishi; Masaki Sekino; Fukiko Nakajo; Yoshifumi Abe; Yasushi Terazono; Ohsaki Hiroyuki; Fusao Kato; Schuichi Koizumi; Christian Gachet; Tatsuhiro Hisatsune
Journal:  J Neuroinflammation       Date:  2013-07-29       Impact factor: 8.322

9.  Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.

Authors:  Annie M Racine; Nagesh Adluru; Andrew L Alexander; Bradley T Christian; Ozioma C Okonkwo; Jennifer Oh; Caitlin A Cleary; Alex Birdsill; Ansel T Hillmer; Dhanabalan Murali; Todd E Barnhart; Catherine L Gallagher; Cynthia M Carlsson; Howard A Rowley; N Maritza Dowling; Sanjay Asthana; Mark A Sager; Barbara B Bendlin; Sterling C Johnson
Journal:  Neuroimage Clin       Date:  2014-02-19       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.